Agilent Technologies Inc
A
$146.36 2.09%
Exchange: NYSE | Sector: Healthcare | Industry: Medical Diagnostics Research
Q1 2025
Published: Mar 3, 2025

Earnings Highlights

  • Revenue of $1.68B up 1.4% year-over-year
  • EPS of $1.11 decreased by 5.9% from previous year
  • Gross margin of 53.6%
  • Net income of 318.00M
  • "Padraig McDonnell stated, 'The Infinity III has seen great adoption from all our customers, driving our top-line growth.'" - Padraig McDonnell

Agilent Technologies Inc (A) Q1 2025 Earnings Report: A Strong Start with Room for Growth

Executive Summary

In Q1 of fiscal year 2025, Agilent Technologies Inc reported revenue of $1.681 billion, reflecting a year-on-year increase of 1%. The performance was primarily driven by strong growth in the Food and PFAS markets, as well as a successful launch of the Infinity III series, which bolstered instrument sales. However, management acknowledged headwinds in the Academia and Government segment, experiencing a 7% decline due to reduced federal funding and uncertainties surrounding NIH budgets. Despite these challenges, the company is optimistic about future growth, particularly in the Chinese market where it has secured significant stimulus-related orders. CEO Padraig McDonnell noted, 'We had a very solid start to the year, exceeding our expectations for core revenue growth and EPS.' Overall, the outlook remains cautiously positive as Agilent continues to navigate an evolving economic landscape and implement its Ignite Transformation strategy.

Key Performance Indicators

Revenue

1.68B
QoQ: -1.18% | YoY:1.39%

Gross Profit

901.00M
53.60% margin
QoQ: -1.64% | YoY:-1.31%

Operating Income

376.00M
QoQ: -7.84% | YoY:-6.00%

Net Income

318.00M
QoQ: -9.40% | YoY:-8.62%

EPS

1.12
QoQ: -7.44% | YoY:-5.88%

Revenue Trend

Margin Analysis

Key Insights

  • **Revenue**: $1.681 billion, up 1% YoY.
  • **Gross Profit**: $901 million, with a gross margin of 53.6%.
  • **Operating Income**: $376 million, with operating margins of 22.4%.
  • **Net Income**: $318 million, with a net profit margin of 18.9%.
  • **EPS**: $1.12, showing a slight decline compared to prior year.

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 1,668.00 0.75 +6.0% View
Q1 2025 1,681.00 1.11 +1.4% View
Q4 2024 1,701.00 1.21 +0.8% View
Q3 2024 1,578.00 0.97 -5.6% View
Q2 2024 1,573.00 1.05 -8.4% View